Literature DB >> 31320275

Longitudinal assessment of autonomic dysfunction in early Parkinson's disease.

Iva Stanković1, Igor Petrović2, Tatjana Pekmezović3, Vladana Marković2, Tanja Stojković2, Nataša Dragašević-Mišković2, Marina Svetel2, Vladimir Kostić4.   

Abstract

INTRODUCTION: Clinical correlates of autonomic nervous system (ANS) dysfunction in early Parkinson's disease (PD) have been addressed mainly in a cross-sectional way.
METHODS: This is a combined cross-sectional and longitudinal prospective study of ANS dysfunction using the SCOPA-AUT in PD patients at the Hoehn and Yahr stage 1 with disease duration <2 years. PD patients (n = 107) were compared to healthy controls (HC, n = 79), and then followed-up for over 3 years. The severity of PD, depression, anxiety, apathy and cognitive impairment were evaluated using rating scales.
RESULTS: At least one symptom of ANS dysfunction was present in 71% of PD patients in comparison to 30.4% of HC, and in all PD patients after three years. The overall severity of dysautonomia symptoms was mild (SCOPA-AUT mean ± SD; 4.16 ± 5.0), but worsened by 23%, 86% and 0.3% during the 1st, 2nd and 3rd year respectively. Nighttime voiding (38.3%), constipation (30.8%) and straining for defecation (29%) were the most common symptoms. Prevalence and severity of urinary, gastrointestinal, and orthostatic symptoms increased, in contrast to thermoregulatory and pupillomotor symptoms. Frequency of symptoms suggestive of multi-domain ANS dysfunction rose from 49% to 79%. Psychiatric symptoms and age, but not motor impairment, were associated with dysautonomia symptoms.
CONCLUSION: Symptoms of ANS dysfunction were frequent in the initial motor stage of PD and progressed, yet remaining mild, within 3 years. An independent progression of dysautonomia symptoms from motor disability and its associations with non-motor, mainly psychiatric symptoms and age support the non-motor clustering in PD.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autonomic; Early; Parkinson's disease

Mesh:

Year:  2019        PMID: 31320275     DOI: 10.1016/j.parkreldis.2019.07.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  13 in total

Review 1.  Clinical features associated with drooling in Parkinson's disease.

Authors:  David Nascimento
Journal:  Neurol Sci       Date:  2021-01-14       Impact factor: 3.307

Review 2.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

3.  Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.

Authors:  Vincenzo Provitera; Valeria Iodice; Fiore Manganelli; Stefania Mozzillo; Giuseppe Caporaso; Annamaria Stancanelli; Ilaria Borreca; Marcello Esposito; Raffaele Dubbioso; Rosa Iodice; Floriana Vitale; Shiwen Koay; Ekawat Vichayanrat; Fernanda Valerio; Lucio Santoro; Maria Nolano
Journal:  Neurology       Date:  2022-01-11       Impact factor: 9.910

4.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

5.  Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease.

Authors:  Katherine Longardner; Aristide Merola; Irene Litvan; Alberto Maria De Stefano; Simona Maule; Fabrizio Vallelonga; Leonardo Lopiano; Alberto Romagnolo
Journal:  J Neurol       Date:  2022-06-16       Impact factor: 6.682

6.  Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson's Disease.

Authors:  Daniel Martinez-Ramirez; Edna Sophia Velazquez-Avila; Alejandro Almaraz-Espinoza; Arnulfo Gonzalez-Cantú; Genaro Vazquez-Elizondo; Daniel Overa-Posada; Amin Cervantes-Arriaga; Mayela Rodriguez-Violante; Mirna Gonzalez-Gonzalez
Journal:  Parkinsons Dis       Date:  2020-10-17

Review 7.  Autonomic Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 8.  Neuro-Immunity and Gut Dysbiosis Drive Parkinson's Disease-Induced Pain.

Authors:  Katiane Roversi; Natalia Callai-Silva; Karine Roversi; May Griffith; Christos Boutopoulos; Rui Daniel Prediger; Sébastien Talbot
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

Review 9.  Pathophysiology and Symptomatology of Drooling in Parkinson's Disease.

Authors:  Sotirios Polychronis; Grigorios Nasios; Efthimios Dardiotis; Lambros Messinis; Gennaro Pagano
Journal:  Healthcare (Basel)       Date:  2022-03-11

10.  Neurodegeneration in the centrally-projecting Edinger-Westphal nucleus contributes to the non-motor symptoms of Parkinson's disease in the rat.

Authors:  Balázs Ujvári; Bence Pytel; Zsombor Márton; Máté Bognár; László Ákos Kovács; József Farkas; Tamás Gaszner; Gergely Berta; Angéla Kecskés; Viktória Kormos; Boglárka Farkas; Nóra Füredi; Balázs Gaszner
Journal:  J Neuroinflammation       Date:  2022-02-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.